ABOUT COMPANY :
MSN
Group is the fastest growing research-based pharmaceutical company based out of
India. Founded in 2003 with a mission to make health care affordable, this
Hyderabad-based venture has nine API and five finished dosage facilities
established across Hyderabad, USA and Myanmar.
The group has an integrated R&D center for both API and formulation under
one roof, dedicated to research and development of pharmaceuticals to make them
more accessible. With core focus on speed and consistency in delivery, MSN has
achieved the following:
·
More than 650 national and
international patents
·
Product portfolio featuring over 350
+ APIs
·
250+ Formulations, covering over 35
major therapies
·
Won the trust of more than
40,000,000 customers across 65 countries globally
Innovation and speed form the crux
of our business strategy. Backed by a dedicated and experienced team of over
11,000 the organizational environment at MSN integrates multiple disciplines
and functions by effective implementation of goals and objectives through
technology, coupled with Integrity, Imagination and Innovation.
Proactive marketing, robust IP strategy, innovative
R&D expertise, dynamic SCM, Insight driven IT and World class facilities
are our ingredients to success.
In a short span of 17 years, we
achieved a record growth of 100% from USD 22 million in 2005 to USD 500 million
in 2019. Outstanding workforce, cutting-edge science, state-of-the-art
technology and knowledge-intensive initiatives - our work involves creating
innovative solutions for tomorrow's healthcare requirements.
For more updates
follow
Thank you for visiting my
website, Visit again for
